- Home
- KLTOW vs ESNT Comparison
KLTOW vs ESNT Comparison
Compare KLTOW & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTOW
- ESNT
- Stock Information
- Founded
- KLTOW N/A
- ESNT 2008
- Country
- KLTOW United States
- ESNT Bermuda
- Employees
- KLTOW 3
- ESNT N/A
- Industry
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- ESNT Property-Casualty Insurers
- Sector
- KLTOW Health Care
- ESNT Finance
- Exchange
- KLTOW Nasdaq
- ESNT Nasdaq
- Market Cap
- KLTOW N/A
- ESNT N/A
- IPO Year
- KLTOW 2022
- ESNT 2013
- Fundamental
- Price
- KLTOW $0.41
- ESNT $59.27
- Analyst Decision
- KLTOW
- ESNT Buy
- Analyst Count
- KLTOW 0
- ESNT 7
- Target Price
- KLTOW N/A
- ESNT $63.29
- AVG Volume (30 Days)
- KLTOW N/A
- ESNT 645.1K
- Earning Date
- KLTOW N/A
- ESNT 08-01-2025
- Dividend Yield
- KLTOW N/A
- ESNT 2.08%
- EPS Growth
- KLTOW N/A
- ESNT 3.49
- EPS
- KLTOW N/A
- ESNT 6.84
- Revenue
- KLTOW N/A
- ESNT $1,262,105,000.00
- Revenue This Year
- KLTOW N/A
- ESNT $5.40
- Revenue Next Year
- KLTOW N/A
- ESNT $3.66
- P/E Ratio
- KLTOW N/A
- ESNT $8.71
- Revenue Growth
- KLTOW N/A
- ESNT 9.57
- 52 Week Low
- KLTOW N/A
- ESNT $51.61
- 52 Week High
- KLTOW N/A
- ESNT $65.34
- Technical
- Relative Strength Index (RSI)
- KLTOW N/A
- ESNT 55.07
- Support Level
- KLTOW N/A
- ESNT $57.16
- Resistance Level
- KLTOW N/A
- ESNT $59.50
- Average True Range (ATR)
- KLTOW 0.00
- ESNT 0.97
- MACD
- KLTOW 0.00
- ESNT 0.06
- Stochastic Oscillator
- KLTOW 0.00
- ESNT 69.09
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.